Chung Wendy
SEC insider (Form 3/4/5 filer). CIK 0001922605. Director at Rallybio Corp (RLYB) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in EAST BERLIN, CT.
Companies Chung Wendy has filed insider reports for
- Rallybio Corp (RLYB): Director
- Prime Medicine, Inc. (PRME): Director
Chung Wendy
CIK: 0001922605
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 16, 2026RLYB
Rallybio Corp
ExerciseDirect3.6K shares at avg. $2.38$8K - Jun 5, 2026PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
75K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
13.5K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
9K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
9K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
39.1K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
39.1K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
45K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
45K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
13.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 |  RLYB Rallybio Corp | Exercise | 3,562 | $2.38 | $8,478 | Direct |
| Jun 5, 2026 |  PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 13,510 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 9,006 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 9,006 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 39,062 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 39,062 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 45,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 13,510 | - | - | Direct |
1-10 of 12 transactions